This presentation in the ISPE Singapore aims to present the state-of-the-art in GMP equipment design and manufacturing for antibody production via some Success Stories in the past 5 years. It will provide a forum for extensive interactions between investigators from both industry and academia. Goals of this video conference include discussion of recent breakthroughs in identifying therapeutics from patients, understanding vaccination and mode of delivery, modalities for half-life extensions and involvement of complement in antibody mode of action. It is anticipated that research in the field will showcase the rise of bispecific antibodies and highlight the technologies to develop them, improve their functionalities, and boost clinical efficacies, particularly in immune-oncology.

Speaker:
Doru Felezeu, Marketing & Business Development Director, Pierre Guerin, France